147 Phase I pharmacokinetic (PK) and safety study of the antiangiogenic peptide ATN-161 (Ac-PHSCN-NH2) in patients with solid tumors
M.E. Cianfrocca, J. Gallo, T. Cardoso, J.W. Lee, K.A. Kimmel, G. Hudes, N. Lewis, L. Weiner, R.B. CohenVolume:
2
Year:
2004
Language:
english
DOI:
10.1016/s1359-6349(04)80155-1
File:
PDF, 148 KB
english, 2004